222 related articles for article (PubMed ID: 10235148)
1. Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
Nilsson O; Tisell LE; Jansson S; Ahlman H; Gimm O; Eng C
JAMA; 1999 May; 281(17):1587-8. PubMed ID: 10235148
[No Abstract] [Full Text] [Related]
2. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
[TBL] [Abstract][Full Text] [Related]
3. Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
Moers AM; Landsvater RM; Schaap C; Jansen-Schillhorn van Veen JM; de Valk IA; Blijham GH; Höppener JW; Vroom TM; van Amstel HK; Lips CJ
Am J Med; 1996 Dec; 101(6):635-41. PubMed ID: 9003111
[TBL] [Abstract][Full Text] [Related]
4. Composite phaeochromocytoma-ganglioneuroblastoma in a patient with multiple endocrine neoplasia type IIA.
Matias-Guiu X; Garrastazu MT
Histopathology; 1998 Mar; 32(3):281-2. PubMed ID: 9568520
[No Abstract] [Full Text] [Related]
5. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
6. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
[TBL] [Abstract][Full Text] [Related]
7. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
[TBL] [Abstract][Full Text] [Related]
8. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation.
Jimenez C; Habra MA; Huang SC; El-Naggar A; Shapiro SE; Evans DB; Cote G; Gagel RF
J Clin Endocrinol Metab; 2004 Aug; 89(8):4142-5. PubMed ID: 15292360
[TBL] [Abstract][Full Text] [Related]
9. Multiple endocrine neoplasia type 2: clinical aspects.
Gimm O
Front Horm Res; 2001; 28():103-30. PubMed ID: 11443849
[No Abstract] [Full Text] [Related]
10. RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?
Gimm O; Niederle BE; Weber T; Bockhorn M; Ukkat J; Brauckhoff M; Thanh PN; Frilling A; Klar E; Niederle B; Dralle H
Surgery; 2002 Dec; 132(6):952-9; discussion 959. PubMed ID: 12490841
[TBL] [Abstract][Full Text] [Related]
11. [A case of multiple endocrine neoplasia type 2A (MEN2A) with a mutation in the RET gene].
Ishizu K; Shiraishi K; Kawamura H; Naito K; Takahashi T; Yoshimura K; Tangoku A; Shirahama S
Hinyokika Kiyo; 1999 Jun; 45(6):407-10. PubMed ID: 10442282
[TBL] [Abstract][Full Text] [Related]
12. Treatment of minute medullary thyroid carcinoma in multiple endocrine neoplasia 2A families first diagnosed by DNA analysis of RET proto-oncogene mutations: a case report.
Yamashita T; Lihara M; Okamoto J; Kanbe M; Ito Y; Kawakami M; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Feb; 27(1):42-5. PubMed ID: 9070340
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
Eng C; Foster KA; Healey CS; Houghton C; Gayther SA; Mulligan LM; Ponder BA
Br J Cancer; 1996 Aug; 74(3):339-41. PubMed ID: 8695346
[TBL] [Abstract][Full Text] [Related]
14. RET proto-oncogene mutations and rearrangements in endocrine diseases.
Lloyd RV
Am J Pathol; 1995 Dec; 147(6):1539-44. PubMed ID: 7495277
[No Abstract] [Full Text] [Related]
15. Genotype-phenotype correlation of patients with multiple endocrine neoplasia type 2 in Japan.
Egawa S; Futami H; Takasaki K; Iihara M; Okamoto T; Kanbe M; Ohi T; Saio Y; Miyauchi A; Takiyama Y; Koga M; Miyanaga K; Inoue K; Mitsuyama S; Nomura Y; Takei H; Mugiya S; Ishida O; Zeze F; Shakutsui S; Inoue H; Oya H; Yoshimura A; Ishizuka S; Yamaguchi K
Jpn J Clin Oncol; 1998 Oct; 28(10):590-6. PubMed ID: 9839497
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.
Eng C; Mulligan LM
Hum Mutat; 1997; 9(2):97-109. PubMed ID: 9067749
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and genetic screening of an extended family with MEN2A.
Algün E; Abaci N; Kösem M; Kotan C; Köseoğlu B; Boztepe H; Sekeroğlu R; Aslan H; Topal C; Ayakta H; Uygan I; Alagöl F; Erginel-Unaltuna N; Aksoy H
J Endocrinol Invest; 2002; 25(7):603-8. PubMed ID: 12150334
[TBL] [Abstract][Full Text] [Related]
18. Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome.
Poturnajova M; Altanerova V; Kostalova L; Breza J; Altaner C
J Mol Med (Berl); 2005 Apr; 83(4):287-95. PubMed ID: 15592804
[TBL] [Abstract][Full Text] [Related]
19. Multiple endocrine neoplasia type iia: report of a family with a study of three generations in qatar.
Zirie M; Mohammed I; El-Emadi M; Haider A
Endocr Pract; 2001; 7(1):19-27. PubMed ID: 11250764
[TBL] [Abstract][Full Text] [Related]
20. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
